Abstract
We report the case of a preterm male infant with a gestational age of 28 + 1 weeks and birth weight of 715 g who presented with life-threatening haematuria on day 28 of life. The haematuria was unresponsive to administration of platelet concentrates and fresh frozen plasma, but then successfully treated with recombinant factor VIIa. The resulting obstructive uropathy was managed by continuous bladder irrigation through suprapubic and urethral catheters. No other adverse affects were noted, and the boy was discharged from the hospital on day 108 of life.
| Original language | English |
|---|---|
| Journal | Blood Coagulation and Fibrinolysis |
| Volume | 20 |
| Issue number | 7 |
| Pages (from-to) | 601-604 |
| Number of pages | 4 |
| ISSN | 0957-5235 |
| DOIs | |
| Publication status | Published - 10.2009 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being -
SDG 5 Gender Equality
Research Areas and Centers
- Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)
Fingerprint
Dive into the research topics of 'Successful use of recombinant factor VIIa in a preterm infant with life-threatening haematuria'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver